About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Search This Discipline
Journals
High Impact Journals
Most Cited Journals
Most Published Journals
Authors
Most Cited Authors
Most Published Authors
Affiliations
Top Institutions
Top Schools
exaly
›
Disciplines
›
Hematology
›
Top Articles
Hematology
148
Journals
668.9K
Articles
12.3M
Citations
108.5K
Authors
Most Cited Articles of Hematology in 2010
Title
Journal
Year
Citations
Cancer statistics, 2010
Ca-A Cancer Journal for Clinicians
2010
11K
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Blood
2010
2.5K
Nomenclature of monocytes and dendritic cells in blood
Blood
2010
1.6K
International consensus report on the investigation and management of primary immune thrombocytopenia
Blood
2010
1.4K
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
Blood
2010
1.4K
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity
Thrombosis and Haemostasis
2010
1.2K
What are biomarkers?
Current Opinion in HIV and AIDS
2010
1.1K
Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma
Ca-A Cancer Journal for Clinicians
2010
950
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
Blood
2010
929
Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
Blood
2010
903
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
Blood
2010
886
Recurrent BRAF mutations in Langerhans cell histiocytosis
Blood
2010
791
Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation
Blood
2010
746
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
Blood
2010
737
gammaH2AX: a sensitive molecular marker of DNA damage and repair
Leukemia
2010
717
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
Blood
2010
680
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis
Journal of Thrombosis and Haemostasis
2010
655
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
Blood
2010
645
Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell-mediated B-cell cytotoxicity
Blood
2010
635
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project
Blood
2010
624
American Cancer Society guideline for the early detection of prostate cancer: update 2010
Ca-A Cancer Journal for Clinicians
2010
616
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Blood
2010
612
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
Blood
2010
610
Improved survival of children and adolescents with sickle cell disease
Blood
2010
599
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Blood
2010
595
site/software ©
exaly
; All materials licenced under
CC by-SA
.